Deadline: 31 Aug 2026

Switzerland

Ref. No.: 25328065

EMD:Ref Document

Bid Value: Ref Document

77 Days Left

Conclusion Not Excluding Drug Discount Agreement According To Section 130A Paragraph 8 Sgb V Through An Open House Model For The Active Ingredient Filgrastim Atc Code According To Who L03Aa02

Deadline: 30 Apr 2028

Germany

Ref. No.: 25325523

EMD:Ref Document

Bid Value: Ref Document

685 Days Left

Establishment Of A Dynamic System For The Acquisition Of Computer Equipment And Furniture At The University Of C rdoba

Deadline: 01 Sep 2026

Spain

Ref. No.: 25324631

EMD:Ref Document

Bid Value: Ref Document

78 Days Left

2026 Panel Memebership For Provision Of Suitable Sites For Adventure Trips For Lcetb Students

Deadline: 24 Feb 2027

Ireland

Ref. No.: 25324312

EMD:Ref Document

Bid Value: Ref Document

254 Days Left

Dynamic Purchasing System 2 0 Port Of Rotterdam N V

Deadline: 31 Mar 2028

Netherlands

Ref. No.: 25322389

EMD:Ref Document

Bid Value: Ref Document

655 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ustekinumab

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320362

EMD:Ref Document

Bid Value: Ref Document

605 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Tocilizumab

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320331

EMD:Ref Document

Bid Value: Ref Document

605 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Teriparatide

Deadline: 10 Nov 2027

Germany

Ref. No.: 25320290

EMD:Ref Document

Bid Value: Ref Document

513 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Somatropin

Deadline: 10 Aug 2027

Germany

Ref. No.: 25320266

EMD:Ref Document

Bid Value: Ref Document

421 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Ranibizumab

Deadline: 10 Feb 2027

Germany

Ref. No.: 25320246

EMD:Ref Document

Bid Value: Ref Document

240 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Pegfilgrastim

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320219

EMD:Ref Document

Bid Value: Ref Document

605 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Omalizumab

Deadline: 10 Aug 2026

Germany

Ref. No.: 25320192

EMD:Ref Document

Bid Value: Ref Document

56 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Infliximab For Subcutaneous Administration

Deadline: 10 Feb 2027

Germany

Ref. No.: 25320164

EMD:Ref Document

Bid Value: Ref Document

240 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130 A Paragraph 8 Sgb V With The Active Ingredient Golimumab

Deadline: 10 Feb 2027

Germany

Ref. No.: 25320145

EMD:Ref Document

Bid Value: Ref Document

240 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V With The Active Ingredient Follitropin Alfa

Deadline: 10 Feb 2028

Germany

Ref. No.: 25320124

EMD:Ref Document

Bid Value: Ref Document

605 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!